| | | | | | | |
 | JOHNSON & JOHNSON | -0.16% | 3.70% | -9.42% | -7.27% | 8.26% | 447 623 |
| ELI LILLY AND COMPANY | 0.09% | 0.84% | 21.92% | 50.18% | 195.39% | 423 414 |
 | NOVO NORDISK A/S | -0.67% | 0.98% | 16.38% | 38.95% | 149.91% | 353 287 |
| MERCK & CO., INC. | 0.35% | -1.61% | -0.22% | 26.99% | 35.39% | 280 920 |
 | ROCHE HOLDING AG | -0.65% | -3.65% | -2.89% | -10.14% | -15.04% | 252 734 |
| ABBVIE INC. | 0.39% | 0.96% | -14.50% | -3.51% | 42.60% | 243 790 |
 | ASTRAZENECA PLC | -0.32% | -0.31% | 4.40% | 18.89% | 39.36% | 228 337 |
| PFIZER, INC. | -0.31% | 1.59% | -23.95% | -22.01% | 8.49% | 219 998 |
| NOVARTIS AG | -0.22% | 0.90% | 7.87% | 7.45% | 7.73% | 209 600 |
| BRISTOL-MYERS SQUIBB COMPANY | -0.78% | 0.97% | -9.94% | -13.70% | 7.71% | 136 135 |
 | SANOFI | -0.04% | 0.44% | 6.19% | -1.52% | 5.19% | 128 138 |
| AMGEN INC. | -0.91% | 3.03% | -16.71% | -8.85% | -3.68% | 116 889 |
| GILEAD SCIENCES, INC. | -0.36% | 2.87% | -9.00% | 28.61% | 1.36% | 97 443 |
| GSK PLC | 0.20% | 0.76% | -4.15% | -36.52% | -33.21% | 70 242 |
 | DAIICHI SANKYO CO., LTD. | 3.57% | 4.20% | 15.51% | 45.67% | 64.22% | 67 564 |
| | | | | | | |
| | Media | 0.01% | 1.04% | -1.23% | 7.55% | 34.25% | |
| | Media ponderata per Capi. | -0.13% | 0.87% | 0.39% | 11.34% | 52.44% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
